Join Our Support & Savings Program

Sign Up and Get:

Auvi‑Q $0 Copay Offer*

Most patients pay $0 out of pocket for Auvi‑Q prescriptions through December 31, 2014.

Refill Reminders

We'll send you alerts when your Auvi‑Q prescription is about to expire, so you'll know to refill it.

Handy Tools

Enjoy access to helpful tools like the Summer Guide and the Find the Sneaky Allergen Quiz.

The Let’s Talk Auvi‑Q Support Program offers everything you see here. Sign up by filling out this simple registration form. All fields are required unless specified.

Already registered? Click here to access your 2014 Auvi‑Q $0 copay card.*

Please fix the errors below.
Tell us about yourself

Who is at risk for a severe allergic reaction in your household? Check all that apply.
Do you or someone in your household currently have an epinephrine auto-injector (EAI)?

Set up your refill reminders below (optional). You can get e‑mail reminders for up to 10 devices.

Device Type
Expiration Date
Location (optional)
[X]

By clicking the “Join Now” button, I agree that the information provided above may be used by Sanofi US, its affiliates and the business service companies working with Sanofi US to provide me information on severe allergies and anaphylaxis and to develop products and services concerning severe allergies and anaphylaxis which may include market research.

To be removed from our mailing list, please visit https://unsubscribe.sanofi-aventis.us or call 1‑800‑207‑8049.

Sanofi US respects your interest in keeping your personal information private. We will not sell or rent your information to any outside mailing lists.

For more information, click to view our Privacy Policy.

*Terms and Conditions
Eligible Patients: Maximum benefit of $100 per two‑pack of Auvi‑Q, up to a maximum of three two‑packs per prescription. This offer can be used an unlimited number of times until 12/31/2014. Prescriber ID# required on prescription. This offer is not valid for prescriptions covered by or submitted for reimbursement under Medicaid, Medicare, or similar federal or state programs including any state medical pharmaceutical assistance program.

Patient Instructions: If prescription is covered by insurance, you may need to notify the insurance carrier of redemption of this copay card. Patient not eligible if prescriptions are paid in part or full by any state or federally funded programs, including, but not limited to, Medicare or Medicaid. In order to redeem this card you must have a valid prescription for Auvi‑Q. Follow the dosage instructions given by the doctor. This card may not be redeemed for cash. Only one card per patient. For questions regarding your eligibility or benefits or if you wish to discontinue your participation, please call 1‑855‑226‑3941.

Pharmacist Instructions for a Patient with an Eligible Third Party: Submit the claim to the primary Third‑Party Payer first, then submit the balance due to Therapy First Plus as a Secondary Payer coordination of benefits with patient responsibility amount and a valid Other Coverage Code (e.g., 8). The Patient pay amount submitted will be reduced by up to $100 per two‑pack. Reimbursement will be received from Therapy First Plus.

Pharmacist Instructions for a Cash‑Paying Patient: Submit the claim to Therapy First Plus. A valid Other Coverage Code (e.g., 1) is required. The Patient pay amount submitted will be reduced by up to $100 per two‑pack. Reimbursement will be received from Therapy First Plus.

Valid Other Coverage Code required. For any questions regarding Therapy First Plus online processing, please call the Help Desk at 1‑800‑422‑5604.

The card is not transferable and the amount of the rebate cannot exceed the patient's out‑of‑pocket expenses. Program expires 12/31/2014. Program managed by PSKW, LLC on behalf of sanofi‑aventis U.S., LLC. Product dispensed pursuant to program rules and federal and state laws. The parties reserve the right to amend or end this program at any time without notice.

SEE MORE

Indication

Auvi‑Q™ (epinephrine injection, USP) is used to treat life-threatening allergic reactions (anaphylaxis) in people who are at risk for or have a history of these reactions.

Important Safety Information

Auvi-Q is for immediate self (or caregiver) administration and does not take the place of emergency medical care. Seek immediate medical treatment after use. Each Auvi-Q contains a single dose of epinephrine. Auvi‑Q should only be injected into your outer thigh. DO NOT INJECT INTO BUTTOCK OR INTRAVENOUSLY. If you accidentally inject Auvi‑Q into any other part of your body, seek immediate medical treatment. Epinephrine should be used with caution if you have heart disease or are taking certain medicines that can cause heart‑related (cardiac) symptoms.

If you take certain medicines, you may develop serious life-threatening side effects from epinephrine. Be sure to tell your doctor all the medicines you take, especially medicines for asthma. Side effects may be increased in patients with certain medical conditions, or who take certain medicines. These include asthma, allergies, depression, thyroid disease, Parkinson's disease, diabetes, high blood pressure, and heart disease.

The most common side effects may include increase in heart rate, stronger or irregular heartbeat, sweating, nausea and vomiting, difficulty breathing, paleness, dizziness, weakness or shakiness, headache, apprehension, nervousness, or anxiety. These side effects go away quickly, especially if you rest.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please click here for full Prescribing Information.

The health information contained herein is provided for general educational purposes only. Your healthcare professional is the single best source of information
regarding your health. Please consult your healthcare professional if you have any questions about your health or treatment.

Unsubscribe | Site Map | FAQs

© 2002-2014 sanofi-aventis U.S. LLC. All rights reserved.
Legal Disclaimer Information and Privacy Policy
US.EAI.14.01.040 Last Update: January 2014

You Are About to Leave a Sanofi US Web Site

Please note:

By clicking on this link, you will be leaving this Sanofi US Web site and going to another, entirely independent, Web site. Sanofi US provides these links as a service to its Web site visitors and users; however, it takes no responsibility for the information on any Web site but its own.

Click the "Continue" button below to go to the page you requested or click "Cancel" to remain on the page.

Cancel